Oncotarget
Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases.The term was introduced in the inaugural Editorial,Introducing Oncotarget.
As of January 1, 2022,Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
SSP 47th Annual Meeting
Post-Publication Promotion
Learn about ourFREE
Impact Journals, LLC is the publisher of Oncotarget:www.impactjournals.com.
Impact Journals is a member of theWellcome Trust List of Compliant Publishers.
Impact Journals is a member of theSociety for Scholarly Publishing.
On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control.This malicious action will be reported to the FBI.
Current Volume
This Month's Popular DOIs
(Crossref resolutions)
| 10.18632/ONCOTARGET.6429 |
| 10.18632/ONCOTARGET.5435 |
| 10.18632/ONCOTARGET.19087 |
| 10.18632/ONCOTARGET.9859 |
| 10.18632/ONCOTARGET.23208 |
Most popular Oncotarget DOIs, measured by the number of times each DOI was successfully resolved.
Most Popular DOIs Published in 2024
(Crossref Data)
Most Popular DOIs of 2024
(Crossref Data)
Milestones in Modern Scholarly Publishing
On August 25, 2022, the Office of Science and Technology Policy announced a new government policy legislating the immediate public release of all United States-funded research publications by 2025.Learn more here.
On May 23, 2023, the Council of the European Union adopted conclusions on high-quality, transparent, open, trustworthy, and equitable scholarly publishing. The Council calls for immediate and unrestricted open access to publishing research involving public funds.Learn more.
Oncotarget.org: Blog Posts on
New & Trending Papers
Oncotarget.net: Latest Insights
From Our Authors
February 8, 2019
About The Cover
The cover for issue 12 of Oncotarget features Figure 1, "Differential responses of females and males to oncogenic challenge," by vanOosterwijk, et al.
Table of Contents
News
| Linking ALDH1 and retinoic acid signaling |
https://doi.org/10.18632/oncotarget.26661 Nicholas O. Markham,Won Jae Huh, and Robert J. Coffey |
| 1226-1227 |
| PDF | How to cite |
Editorial
| Why is immunotherapy for glioblastoma “Lag”-ging |
https://doi.org/10.18632/oncotarget.26648 Dimitrios Mathios, and Michael Lim |
| 1228-1229 |
| PDF | How to cite |
| Abemaciclib: A multi-functional radiation modifier |
https://doi.org/10.18632/oncotarget.26652 Sarwat Naz,John A. Cook, and James B. Mitchell |
| 1230-1232 |
| PDF | How to cite |
| Obesity and height in children and adolescents with acute lymphoblastic leukemia and its future management |
https://doi.org/10.18632/oncotarget.26653 Emily K. Browne, and Hiroto Inaba |
| 1233-1234 |
| PDF | How to cite |
Priority Research Perspective
| Sexually dimorphic tumor suppression by small mitochondrialArf |
https://doi.org/10.18632/oncotarget.26651 Jolieke G. van Oosterwijk,Heather Tillman, and Charles J. Sherr |
| 1235-1237 |
| Abstract | PDF | Full Text | How to cite |
Research Papers
| Neutrophil extracellular traps promote peritoneal metastasis of colon cancer cells |
https://doi.org/10.18632/oncotarget.26664 Amr A. Al-Haidari,Nader Algethami,Mattias Lepsenyi,Milladur Rahman,Ingvar Syk, and Henrik Thorlacius |
| 1238-1249 |
| Abstract | PDF | Full Text | How to cite |
Reviews
| Myeloid cell leukemia-1 dependence in acute myeloid leukemia: a novel approach to patient therapy |
https://doi.org/10.18632/oncotarget.26579 Tapan Mahendra Kadia,Hagop M. Kantarjian, and Marina Konopleva |
| 1250-1265 |
| Abstract | PDF | Full Text | How to cite |
Corrections
| Correction: 4-Hydroxyestradiol induces mammary epithelial cell transformation through Nrf2-mediated heme oxygenase-1 overexpression |
https://doi.org/10.18632/oncotarget.26681 Sin-Aye Park,Mee-Hyun Lee,Hye-Kyung Na, and Young-Joon Surh |
| 1266-1266 |
| Correction | PDF | How to cite |
Copyright © 2025 Rapamycin Press LLC dba Impact Journals